PeterCLucasMDPhD

Pathology • Rochester, MN

Molecular Genetics, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor, University of Pittsburgh School of Medicine/UPMC; Director of Pathology, NSABP division of NRG Oncology

Join to view full profile

Dr. Lucas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lucas' full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

University of MichiganResidency, Pathology-Anatomic and Clinical, 1996 - 2001
Vanderbilt University School of MedicineClass of 1996
Vanderbilt UniversityPhD, 1992

Certifications & Licensure

MN State Medical License 2023 - 2025
PA State Medical License 2012 - 2024
MI State Medical License 1999 - 2015
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer.
Fangyuan Chen, Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore
NPJ Precision Oncology. 2024-11-09
mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration.
Ian Eder, Virginia Yu, Jacob Antonello, Fangyuan Chen, David Gau
Molecular Biology of the Cell. 2024-10-01
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression.
Juliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, Hannah E Crentsil, Gabriela N Debom
Biorxiv. 2024-09-27

Press Mentions

How High Fat Foods Impact Diabetes and Metabolic SyndromeMay 22nd, 2012

Grant Support

GPCR signaling through a novel NF-kB pathwayNational Heart, Lung, and Blood Institute (NHLBI)2013–2018
Angiotensin II Signaling Through A Novel Nf-Kb PathwayNational Heart, Lung, And Blood Institute2008–2012
Novel Signal Pathway Mediating Hypertension/Obesity-Dependent Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2011
A Novel Signaling Pathway Mediating Hypertension- And Obesity-Dependent Insulin RNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Nf-Kb Signaling &Molec Pathogenesis Of MALT LymphomaNational Cancer Institute2002–2006
Ciper--A Novel Apoptosis Regulator Involved In CancerNational Cancer Institute2000–2002